Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship Program, Pediatric Hematology/Oncology, 1976
    New York Hospital Cornell Medical Center
  • Residency Program, Pediatrics, 1974
    Children's National Medical Center
  • Internship Program, Pediatrics, 1973
    Children's National Medical Center

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1194802413

Biography

Naomi L. Luban, M.D., is Chair of the IRB, the Medical Director of the Office of Protection of Human Subjects at Children's National Health System, Director of the Blood Donor Center, Associate Program Director for the General Clinical Research Center and Vice Chair for Faculty Affairs at Children's National. She has been an attending physician at Children’s National for more than 30 years.

Dr. Luban has published more than 140 peer-reviewed journal articles and more than 40 book chapters. She has edited seven texts in pediatric transfusion medicine and is an editorial board member for Transfusion and the American Journal of Hematology. In addition, Dr. Luban is a peer-reviewer for Transfusion, JAMA, Immunohematology, the Journal of Pediatrics, Pediatric Blood and Cancer and other publications.

Currently, Dr. Luban is a fellow of the American Academy of Pediatrics, the chair of the Committee on Blood Disorders in Childhood of the American Society of Hematology and a member of the board of trustees of the American Society of Pediatric Hematology/Oncology. Her clinical interests are focused in inherited platelet disorders and hemophilia.

Dr. Luban lives in Maryland and has two children.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • Corman University of Iowa 
  • American Society of Pediatric 
  • Hematology 
  • Oncology 
  • Immucor  

Blood component therapy

(2008) Pediatric Clinics of North America

Blood transfusions in children a multiinstitutional analysis of practices and complications

(2008) Transfusion

Management of anemia in the newborn

(2008) Early Human Development

rs660 polymorphism in Ro52 SSA1 TRIM21 is a marker for agedependent tolerance induction and efficiency of alloimmunization in sickle cell disease

(2009) Molecular Immunology

Sickle cell disease summit from clinical and research disparity to action

(2009) American Journal of Hematology